ASSC Scientific Meeting
Thursday 13 October 2016
8.30am to 12.30pm
Translational Research Institute, Room 2007 TRI
The ASSC Scientific Meeting, held at the Translational Research Institute, will be the official launch of the collaboration between The University of Queensland and QIMR Berghofer Medical Research Institute skin and skin cancer researchers. Following on from the successful first member’s meeting, which outlined the scope of the ASSC, the Scientific Meeting will include cutting edge project presentations, including those which received funding in the first ASSC Enabling Grant Scheme.
| Time | Session | Speaker |
| 8.30am | Welcome and Introduction | Professor H. Peter Soyer Professor David Whiteman |
| ASSC Enabling Grant Scheme Winners Chairs: Prof Soyer and Prof Whiteman |
||
| 8.45am | Research evaluation of the Princess Alexandra Hospital Transplant Clinic: pilot study Presentation available |
A/Prof Nicole Isbel A/Prof Louisa Gordon |
| 9.00am | Pre-clinical development of antigen specific immunotherapy and strategies to overcome regulation in cutaneous malignant melanoma Presentation available |
Prof Riccardo Dolcetti |
| 9.15am | Immune contexture of transforming naevi Presentation available |
Prof Mark Smyth |
| 9.30am | The feasibility of circulating tumour DNA as an alternative to biopsy for mutational characterisation in Stage III melanoma patients Presentation available |
Dr Lauren Aoude |
| 9.45am | Epigenetic modifiers as novel targets for therapy in melanoma | A/Prof Jason Lee A/Prof Helmut Schaider |
| 10.00am | Morning Tea TRI Atrium |
|
| ASSC Showcase Presentations Chairs: A/Prof Khosrotehrani and Prof Hayward |
||
| 10.30am | A Natural History of the Actinic Keratosis Microbiome in Immunocompetent Men | Dr David Wood |
| 10.45am | The Australian Melanoma Genome Project | Prof Nicholas Hayward |
| 11.00am | What is the role of the epigenome in the control of squamous differentiation and squamous neoplasia | Dr Orla Gannon |
| 11.15am | Incidence, multiplicity and risk of keratinocyte cancer: An update from the QSKIN study. Presentation available |
Prof David Whiteman |
| 11.30am | Cell cycle-tailored targeting of metastatic melanoma: challenges & opportunities | Prof Nikolas Haass |
| 11.45am | Statistical genetics: A Swiss army tool for understanding melanoma risk and outcome Presentation available | A/Prof Stuart MacGregor Dr Matthew Law |
| 12.00pm | Meeting close | |
| 12.05pm | Lunch TRI Atrium |
|
More information on the presentations:
Event programSession ISession II
For more information, contact Melissa Kerr at melissa.kerr@uq.edu.au
